PRKCA and neoplasm: Notwithstanding the lack of an overt tumour driver phenotype in hetero- or homozygous knock-out Prkca mice (13), in principle the effect of the D463H inactivation mutation might still be compatible with a dominant-negative impact on a suppressor Prkca allele as opposed to a gain-of-function allele.